TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+21.81%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$160M
AUM Growth
+$160M
(+13%)
Cap. Flow
+$6.93M
Cap. Flow
% of AUM
4.33%
Top 10 Holdings %
Top 10 Hldgs %
58.41%
Holding
38
New
11
Increased
8
Reduced
9
Closed
8
Top Buys
| 1 |
Nektar Therapeutics
NKTR
|
$11.7M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
$7.48M |
| 3 |
HCA Healthcare
HCA
|
$7.12M |
| 4 |
Brookdale Senior Living
BKD
|
$6.81M |
| 5 |
Boston Scientific
BSX
|
$4.92M |
Top Sells
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$10.6M |
| 2 |
Hologic
HOLX
|
$9.23M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
$8.93M |
| 4 |
NXTM
NxStage Medical Inc.
NXTM
|
$6.91M |
| 5 |
Service Corp International
SCI
|
$3.55M |
Sector Composition
| 1 | Healthcare | 94.78% |
| 2 | Industrials | 4.15% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1
DELISTED
Veradigm Inc. Common Stock
MDRX
| $12.2M | 7.64% | 965,000 +200,000 | +26% | +$2.54M |
|
2
Pacira BioSciences
PCRX
$1.2B
| $12.1M | 7.55% | 265,000 -8,000 | -3% | -$365K |
|
|
3
Nektar Therapeutics
NKTR
$568M
| $11.7M | 7.33% | +500,000 | New | +$11.7M |
|
4
Gilead Sciences
GILD
$140B
| $10.2M | 6.37% | 150,000 +50,000 | +50% | +$3.4M |
|
|
SPNC
5
DELISTED
Spectranetics Corp
SPNC
| $8.74M | 5.46% | 300,000 -29,600 | -9% | -$862K |
|
6
Jazz Pharmaceuticals
JAZZ
$7.75B
| $8.27M | 5.17% | 57,000 -20,000 | -26% | -$2.9M |
|
7
NovoCure
NVCR
$1.38B
| $8.03M | 5.01% | 990,750 +165,750 | +20% | +$1.34M |
|
8
Teladoc Health
TDOC
$1.37B
| $7.63M | 4.76% | 305,000 -110,600 | -27% | -$2.77M |
|
|
WBA
9
DELISTED
Walgreens Boots Alliance
WBA
| $7.48M | 4.67% | +90,000 | New | +$7.48M |
|
|
10
HCA Healthcare
HCA
$94.5B
| $7.12M | 4.45% | +80,000 | New | +$7.12M |
|
11
Labcorp
LH
$23.1B
| $6.89M | 4.3% | 48,000 -3,000 | -6% | -$430K |
|
12
Steris
STE
$24.1B
| $6.82M | 4.26% | 98,150 +35,150 | +56% | +$2.44M |
|
|
13
Brookdale Senior Living
BKD
$1.83B
| $6.81M | 4.25% | +503,000 | New | +$6.81M |
|
|
HIND
14
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $6.05M | 3.78% | 565,912 +3,306 | +0.6% | +$35.3K |
|
|
CORV
15
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $5.49M | 3.43% | 1,825,000 | – | – |
|
|
16
Boston Scientific
BSX
$156B
| $4.97M | 3.11% | 200,000 +197,800 | +8,991% | +$4.92M |
|
17
Alkermes
ALKS
$4.78B
| $4.68M | 2.92% | 80,000 +2,000 | +3% | +$117K |
|
|
CORI
18
DELISTED
Corium International, Inc.
CORI
| $4.44M | 2.78% | 1,063,000 +325,758 | +44% | +$1.36M |
|
19
Lantheus
LNTH
$3.73B
| $3.63M | 2.27% | +290,700 | New | +$3.63M |
|
|
ATHN
20
DELISTED
Athenahealth, Inc.
ATHN
| $3.38M | 2.11% | 30,000 -11,000 | -27% | -$1.24M |
|
|
NXTM
21
DELISTED
NxStage Medical Inc.
NXTM
| $2.95M | 1.84% | 110,000 -257,690 | -70% | -$6.91M |
|
|
SRCL
22
DELISTED
Stericycle Inc
SRCL
| $2.47M | 1.54% | +29,800 | New | +$2.47M |
|
|
ISEE
23
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.72M | 1.08% | +471,149 | New | +$1.72M |
|
|
AKRX
24
DELISTED
Akorn, Inc.
AKRX
| $1.71M | 1.07% | +70,969 | New | +$1.71M |
|
|
NVRO
25
DELISTED
NEVRO CORP.
NVRO
| $1.6M | 1% | +17,100 | New | +$1.6M |
|